Skip to main content

Richard B. Gaynor, M.D.

Equibles does not estimate personal net worth.

Get an email with a short summary when Alkermes plc. publishes a filing, an earnings call transcript or a press release.

Get ALKS alerts

About Richard B. Gaynor, M.D.

Richard B. Gaynor, M.D. is recorded as Board Member at Alkermes plc. (ALKS) since May 20, 2026. Alkermes plc. reported in an 8-K filed May 31, 2024 that Richard B. Gaynor, M.D. was appointed director, effective May 31, 2024. Alkermes plc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Alkermes plc. includes Blair C. Jackson (CEO, CFO and COO), Mr. Richard F. Pops (CEO), Iain M. Brown (CFO and Chief Accounting Officer) and 7 others.

“By separate resolutions, shareholders elected the following directors, each to serve for a one-year term expiring at the Company’s 2025 annual general meeting of shareholders, or until their respective successor is elected and shall qualify, with the votes cast as follows:”
Alkermes plc. Form 8-K, filed May 31, 2024 · Read the filing

Affiliation history

Company network

Current role

Drug Manufacturers - Specialty & Generic · Healthcare

Board Member

2026-05-20–present

Leadership on record at Alkermes plc.

Recent activity